Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study
- PMID: 28918170
- DOI: 10.1016/j.clnu.2017.08.018
Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study
Abstract
Background & aims: Most people with nonalcoholic fatty liver disease (NAFLD) are obese, and they usually eat more while being less physically active as compared to healthy individuals. However, little is known about the lifestyle patterns of non-obese or obese patients with NAFLD. The aim of this study was to investigate nutrition components and behavioral differences between non-obese and obese patients with NAFLD.
Methods: This is a cross-sectional study comprising of 209 patients. Nutritional components and physical activity status were compared in obese and non-obese subjects with NAFLD against healthy controls. Dietary intake was assessed using the 5-day food diary. Physical activity was measured using the protocol of Korea Health and Nutrition Examination Survey. Total and regional body composition analysis was conducted using anthropometry and tetrapolar multi-frequency bio-impedance. Visceral adipose tissue, total abdominal adipose tissue, abdominal subcutaneous adipose tissue as well as liver fat were measured using abdomen tomography.
Results: Non-obese subjects with NAFLD had higher levels of ALT, AST, GGT, triglyceride, fasting glucose; higher carbohydrate energy ratio; higher visceral fat area, subcutaneous area, body muscle mass, fat free mass and body fat compared to subjects without NAFLD. Subjects with obesity and NAFLD had higher ALT, AST, visceral fat, fasting glucose and HOMA-IR (homeostatic model assessment-insulin resistance), and less moderate-level physical activity compared to those with obesity who do not have NAFLD. Obese subjects with NAFLD also had higher blood pressure, visceral fat area, subcutaneous fat area, body fat, body fat percent and GGT compared to non-obese subjects with NAFLD. In multivariate analysis, carbohydrate energy ratio and physical activity less than moderate-level (<2 h/week) were predictors of NAFLD in non-obese subjects independent of the visceral fat, body muscle index, total energy intake, age and sex. Physical activity less than moderate-level was a predictor of NAFLD in obese subjects with NAFLD, independent of the HOMA-IR, visceral fat, total energy intake, fat energy percent, age and sex.
Conclusions: Percentage of carbohydrate intake percent and physical activity, less than moderate-level were independent predictors of NAFLD in non-obese subjects. Meanwhile, physical activity, less than moderate-level, was an independent predictor in obese subjects.
Keywords: Carbohydrate; Non-alcoholic fatty liver; Non-obese.
Copyright © 2017 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
Comment in
-
Reply Letter to the Editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.Clin Nutr. 2018 Apr;37(2):759. doi: 10.1016/j.clnu.2018.01.008. Epub 2018 Feb 15. Clin Nutr. 2018. PMID: 29366517 No abstract available.
-
Comment on: Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.Clin Nutr. 2018 Apr;37(2):758. doi: 10.1016/j.clnu.2018.01.009. Epub 2018 Jan 9. Clin Nutr. 2018. PMID: 29373149 No abstract available.
-
Reply-Letter to the editor-Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.Clin Nutr. 2018 Jun;37(3):1090. doi: 10.1016/j.clnu.2018.01.036. Epub 2018 Feb 15. Clin Nutr. 2018. PMID: 29478888 No abstract available.
Similar articles
-
Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.Nutr Clin Pract. 2013 Feb;28(1):101-11. doi: 10.1177/0884533612454884. Epub 2012 Oct 5. Nutr Clin Pract. 2013. PMID: 23042833
-
Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.Liver Int. 2019 Feb;39(2):332-341. doi: 10.1111/liv.13983. Epub 2018 Oct 27. Liver Int. 2019. PMID: 30298568
-
Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017.BMC Pediatr. 2020 Mar 14;20(1):121. doi: 10.1186/s12887-020-02022-y. BMC Pediatr. 2020. PMID: 32171275 Free PMC article.
-
A review of non-alcoholic fatty liver disease in non-obese and lean individuals.J Gastroenterol Hepatol. 2021 Jun;36(6):1497-1507. doi: 10.1111/jgh.15353. Epub 2020 Dec 15. J Gastroenterol Hepatol. 2021. PMID: 33217052 Review.
-
Association between Non-Alcoholic Fatty Liver Disease and Mediterranean Lifestyle: A Systematic Review.Nutrients. 2021 Dec 23;14(1):49. doi: 10.3390/nu14010049. Nutrients. 2021. PMID: 35010923 Free PMC article.
Cited by
-
MAFLD: an ideal framework for understanding disease phenotype in individuals of normal weight.Ther Adv Endocrinol Metab. 2024 May 27;15:20420188241252543. doi: 10.1177/20420188241252543. eCollection 2024. Ther Adv Endocrinol Metab. 2024. PMID: 38808010 Free PMC article. Review.
-
Relationship between dietary macronutrient composition and non-alcoholic fatty liver disease in lean and non-lean populations: a cross-sectional study.Public Health Nutr. 2021 Dec;24(18):6178-6190. doi: 10.1017/S1368980021001762. Epub 2021 Apr 26. Public Health Nutr. 2021. PMID: 33896439 Free PMC article.
-
Risk factors in nonalcoholic fatty liver disease.Clin Mol Hepatol. 2023 Feb;29(Suppl):S79-S85. doi: 10.3350/cmh.2022.0398. Epub 2022 Dec 14. Clin Mol Hepatol. 2023. PMID: 36517003 Free PMC article. Review.
-
Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study.BMC Public Health. 2022 Jan 17;22(1):118. doi: 10.1186/s12889-021-12486-x. BMC Public Health. 2022. PMID: 35038997 Free PMC article.
-
The Growth Hormone Releasing Hormone Analogue, Tesamorelin, Decreases Muscle Fat and Increases Muscle Area in Adults with HIV.J Frailty Aging. 2019;8(3):154-159. doi: 10.14283/jfa.2018.45. J Frailty Aging. 2019. PMID: 31237318 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous